Dr. Ofra Levy-Hacham
VP Clinical and Regulatory Affairs
Dr. Ofra Levy-Hacham has served as our vice president of clinical and regulatory affairs since March 2018, and before that since joining us in 2011, she served as our vice president of quality and regulatory affairs. Prior to joining Sol-Gel, Dr. Levy-Hacham served as a scientific specialist and project manager at Biotechnology General Ltd., a fully integrated biopharmaceutical services private company from 2010 until 2011. From 2008 until 2010, Dr. Levy-Hacham served as vice president chemistry, manufacturing and controls at HealOr Ltd., a private company engaging in the development of therapeutics for the treatment of various skin lesions and conditions. Dr. Levy-Hacham holds a Ph.D. in chemistry from The Technion - Israel Institute of Technology, Israel.